Vaxil Bio Ltd. (VXL.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1050+0.0050 (+5.00%)
At close: 3:54PM EDT
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.1050 x 0 |
| Ask | 0.1100 x 0 |
| Day's Range | 0.0950 - 0.1100 |
| 52 Week Range | 0.0600 - 0.7700 |
| Volume | 562,234 |
| Avg. Volume | 604,626 |
| Market Cap | 14.346M |
| Beta (5Y Monthly) | -4.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0130 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Vaxil Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company is pleased to announce that the Company has entered into a non-binding letter of intent for the acquisition of 100% of the rights and interests in and to the Short Wave Pharma Inc. (”Shortwave" or "Target") business action (the “Transaction”). Shortwave is an Israeli based pre-clinical stage biote
© 2021 Verizon Media. All rights reserved.
